Zacks Investment Research on MSN11h
FDA Approves Novartis Drug for Rare Kidney Disease TreatmentNovartis NVS announced that the FDA has approved Fabhalta (iptacopan) for a third indication. The regulatory body approved ...
Medical Device Network on MSN12h
FDA tags Becton, Dickinson and Company infusion software recall as Class IProblematic software has been the cause of multiple infusion pump recalls in the medical device industry over the past few years.
Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback